Canine Biologics (2021)

Canine Biologics (2021)

About this raise

Canine Biologics, with a valuation cap of $6.5 million, is raising funds on Wefunder. The company makes nutrition products to support dogs battling cancer. It uses the highest-quality ingredients, top-tier expertise, and inspired thinking to make pet nutrition products with specialized supplements, vitamins, and minerals. Jeff Sutherland founded Canine Biologics in 2019. The proceeds of the current crowdfunding round, with a minimum goal of $50,000 and a maximum goal of $1,070,000, will be used for marketing, sales, payroll, working capital, and administrative costs. Canine Biologics has reported six consecutive months of positive revenue growth. It is a unique company with an expanded product roadmap, including a liquid diet for dogs and formulated treats.

Expand

Investment Overview

Invested this round: $57,571

Deal Terms

Total Commitments

Platform
Wefunder
Start Date
05/05/2021
Close Date
08/14/2021
Min. Goal
$50,000
Max Goal
$1,070,000
Min. Investment

$100

Security Type

SAFE

Company Stage

Early Stage

SEC Filing Type

RegCF    Open SEC Filing

Early Bird Val. Cap

$5,700,000

Valuation Cap

$6,500,000

Discount

0%

Company & Team

Company

Year Founded
2021
Industry
Pet Health, Food, and Services
Tech Sector
Biotech
Distribution Model
B2B/B2C
Margin
Low
Capital Intensity
High
Location
Denver, Colorado
Business Type
Life Style
Company Website
Visit Website

Team

Employees
5
Prior Founder Exits?
No
Founder Name
Jeff Sutherland
Title
CEO

Financials

 Revenue
$5,823
 Monthly Burn
$29,460
 Runway
3.4 months
 Gross Margin
3%

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$5,823

$0

COGS

$5,650

$0

Tax

$0

$0

 

 

Net Income

$-353,517

$-10,497

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$98,886

$119,551

Accounts Receivable

$25,894

$0

Total Assets

$403,282

$146,911

Short-Term Debt

$33,296

$8,409

Long-Term Debt

$0

$0

Total Liabilities

$33,296

$8,409

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Close Date Platform Valuation Total Raised Security Type Status Reg Type
03/08/2022 Netcapital $6,123,284 $39,141 Equity - Common Funded RegCF
08/14/2021 Wefunder $6,500,000 $57,571 SAFE Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.

Growth Charts

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Canine Biologics on Wefunder
Platform: Wefunder
Security Type: SAFE
Valuation: $6,500,000

Follow company

Follow Canine Biologics on Wefunder

Buy Canine Biologics's Deal Report

Warning: according to the close date for this deal, Canine Biologics may no longer be accepting investments.

Canine Biologics Deal Report

Get Kingscrowd's comprehensive report on Canine Biologics including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Canine Biologics is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Canine Biologics deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge